Hydrogen Bromide → HCID 46938209, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@H:8]2[CH2:13][C@@H:12]([C:14]3[O:18][NH:17][C:16](=[O:19])[CH:15]=3)[CH2:11][CH2:10][N:9]2C(OC)=O)=[CH:4][CH:3]=1.Br>>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@H:8]2[CH2:13][C@@H:12]([C:14]3[O:18][NH:17][C:16](=[O:19])[CH:15]=3)[CH2:11][CH2:10][NH:9]2)=[CH:4][CH:3]=1Participants
Procedure
(2R,4S)-Methyl 2-(4-chlorophenyl)-4-(3-oxo-2,3-dihydroisoxazol-5-yl)piperidine-1-carboxylate (0.447 g, 1.33 mmol) was dissolved in hydrogen bromide (33% in acetic acid, 10.46 mL, 59.73 mmol) and the mixture was stirred at room temperature overnight. The solvent was evaporated and the residue purified by preparative HPLC (Instrument: FractionLynx II, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm) to yield 5-((2R,4S)-2-(4-chlorophenyl)piperidin-4-yl)isoxazol-3(2H)-one (233 mg, 63%). 1H NMR (600 MHz, dmso) δ 1.32 (q, 1H), 1.44 (dq, 1H), 1.82-1.88 (m, 1H), 1.90-1.97 (m, 1H), 2.71 (dt, 1H), 2.80-2.88 (m, 1H), 3.06-3.12 (m, 1H), 3.63 (dd, 1H), 5.70 (s, 1H), 7.31-7.35 (m, 2H), 7.35-7.40 (m, 2H). HRMS Calculated for [C14H15ClN2O2+H]+: 279.0900. Found: 279.0905
Workup
- customThe solvent was evaporated
- customthe residue purified by preparative HPLC (Instrument: FractionLynx II, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm)
Sources & evidence
- ORD record
- ord-38ae636d94e04e879dc29dd07e742c30
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08415378B2
Reaction notes
Loading…